SB 009
Alternative Names: SB-009Latest Information Update: 13 Mar 2024
At a glance
- Originator Splice Bio
- Class Eye disorder therapies; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Retinal disorders